Sort
261,768 grants matching “gene therapy”
Reversing Cellular immortality in cancer
$962,915Steven E Artandi · Stanford University · R35 · FY2018 · CA
Reversing Cellular immortality in cancer
$962,884Steven E Artandi · Stanford University · R35 · FY2017 · CA
New Paradigms for Targeting Truncal Driver Mutations
$962,850William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Single nuclei transcriptome profiling in addiction circuitry of the HIV+ brain
$962,838Schahram Akbarian · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · DA
Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics
$962,824Leor S Weinberger · J. David Gladstone Institutes · R37 · FY2021 · AI
THE PHARMACODYNAMICS OF GENES AND OLIGONUCLEOTIDES
$962,793University Of North Carolina Chapel Hill · P01 · FY2004 · GM
Targeting the MYC Pathway for the Treatment of Cancer
$962,720Dean W Felsher · Stanford University · R35 · FY2020 · CA
Safe and effective anti CD154 antibodies for therapeutic intervention
$962,696Matthew F. Mackey · Immunext, Inc. · R44 · FY2014 · AI
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$962,665Mark Reid Philips · New York University School Of Medicine · R35 · FY2023 · CA
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
$962,633Michael D Geschwind · University Of California, San Francisco · R01 · FY2019 · AG
New Paradigms of Cerebral Palsy Etiology: A Comprehensive Case Control Study
$962,602Nigel S Paneth · Michigan State University · R01 · FY2009 · NS
Molecular Therapy Core Center
$962,591Richard C Boucher · Univ Of North Carolina Chapel Hill · P30 · FY2007 · DK
Molecular Therapy Core Center
$962,591Richard C Boucher · Univ Of North Carolina Chapel Hill · P30 · FY2008 · DK
MOLECULAR CLASSIFICATION OF PROSTATE CANCER
$962,585Sloan-Kettering Institute For Cancer Res · U01 · FY2001 · CA
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$962,513Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Characterization and improvement of graft versus leukemia effects
$962,497Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Immunobiology and immunotherapy of leukemia
$962,497Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Development of a protein drug for pancreatic cancer treatment
$962,484Zhi-Ren Liu · Proda Biotech, Llc · U44 · FY2022 · CA
Genetic Determinants of Epilepsy in Murine Systems
$962,316Tristan T Sands · Columbia University Health Sciences · R01 · FY2023 · NS
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodege
$962,241Thomas O Obisesan · Howard University · R01 · FY2010 · AG
Lymphoma Disease Discovery and Definition
$962,212Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Genetics of Asthma and COPD
$962,212Steven D Shapiro · Brigham And Women'S Hospital · P01 · FY2008 · HL
Transcriptional condensates, epigenetic editing and Rett Syndrome
$962,212Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2020 · MH
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
$962,192Giovanna Tosato · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Angiogenesis and Tumor Growth
$962,192Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA